The better the technology, the smaller the things we can see. Semiconductors moved from 180 nm to 130 nm to today’s 2 nm-class nodes. Venom proteomics followed the same curve: over a decade, mass spectrometry pushed the lowest detectable abundance down by an order of magnitude.
Both fields then hit the same wall. Past a certain scale, refining the old method is no longer enough — the method itself has to change. Semiconductors had to replace the transistor architecture; on the analytical side, matrix interference distorts quantitation and the analytical process can rewrite the very molecule being measured.
That is what TRACE works on: however faint the trace, the right method can follow it back. We work with mass spectrometry and biosensing, we build our own tools, and we let the data decide — which is why our topics look scattered while the method stays the same.